Cancer in Medical Products
Navigation Links
Cancer in Medical Products
Description:... with the volume and clinical stage of prostate cancer [1,4]. Selective determination of the various ... PSA to PSA-ACT is lower in untreated prostate cancer patients than in normal individuals or in ... discrimination between BPH and untreated prostate cancer in patients [1,3,5,6].
It has been found ...
Company:Diagnostic Systems Laboratories, Inc.
Company:Beckman Coulter, Inc.
Description:... with the volume and clinical stage of prostate cancer [1,4]. Selective determination of the various ... PSA to PSA-ACT is lower in untreated prostate cancer patients than in normal individuals or in ... discrimination between BPH and untreated prostate cancer in patients [1,3,5,6]. It has been found ...
Company:Diagnostic Systems Laboratories, Inc.
Company:Agendia Corporate
Company:Skyscape, Inc.
Company:Envisioneering Medical Technology
Company:Dade Behring, Inc.
Company:Matritech, Inc.
Company:Matritech, Inc.
Description:... in most tumors. The liver is a principal site for metastasis of primary cancer originating in other parts of the body, particularly colon cancer, which is a common cancer in the United States. The ability to identify metastatic tumors in the ...
Company:Advanced Magnetics, Inc.
Company:Inverness Medical Innovations
Company:Skyscape, Inc.
Description:... traditional guaiac-based FOBTs. Because of its superior specificity for lower GI bleeding, Hemoccult ICT is an ideal screening tool for colorectal cancer (CRC), and this specificity also reduces the number of false positive test results. Safe and non-invasive, Hemoccult ICT is very patient friendly, as ...
Company:Beckman Coulter, Inc.
Company:Beckman Coulter, Inc
Company:BD Diagnostic Systems
Description:... diagnostic test for the clinical evaluation of GH-related disorders. Additionally, there is a growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. Vit Horm 47:1-114, 1993. Juul A. et al. J Clin ...
Company:Diagnostic Systems Laboratories, Inc.
Company:Diagnostic Systems Laboratories, Inc.
Company:Diagnostic Systems Laboratories, Inc.
Company:Diagnostic Systems Laboratories, Inc.
Company:Diagnostic Systems Laboratories, Inc.
Description:... diagnostic test for the clinical evaluation of GH-related disorders. Additionally, there is a growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. Vit Horm 47:1-114, 1993. Juul A. et al. J Clin ...
Company:Diagnostic Systems Laboratories, Inc.
Description:... Oncotype DX™ is a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses ...
Company:Genomic Health, Inc.
Description:... in situ hybridization (FISH) assay designed to quantitatively determine HER2 gene amplification in formalin-fixed, paraffin-embedded breast cancer tissue specimens. Gene amplification is determined from the ratio between the number of signals from the hybridization of the HER2 gene probe (red ...
Company:DakoCytomation California Inc.
Description:... The Her-2/neu protein is a 185 kD trans-membrane glycoprotein associated with tyrosine kinase activity. Approximately 20-30% cases of breast cancer show an amplification and/or over-expression of Her-2/neu in tumor cells. Since the introduction of Herceptin® as a targeted therapy for breast ...
Company:BioGenex Laboratories
Company:FCI Ophthalmics Inc.
Company:IDS Ltd
Description:... tool in determining functionality of a patient's immune system, particularly important when deciding courses of treatment for patients receiving cancer chemotherapy, immunosuppressive treatment, recurring infections and autoimmune dieseases. Kit 030 designed especially for patients with autoimmune ...
Company:AntibodyShop A/S
Description:... tool in determining functionality of a patient's immune system, particularly important when deciding courses of treatment for patients receiving cancer chemotherapy, immunosuppressive treatment, recurring infections and autoimmune ....
Company:AntibodyShop A/S
Company:Bio-Rad Laboratories
Company:Abbott Diagnostics
Description:... A Powerful New Quantitative Immunoassay for Monitoring Bladder cancer Patients. Useful in Monitoring Patients for Disease Progression and ....
Company:Polymedco Inc.
Description:... office with results delivered during the patient visit, allowing a rapid, accurate and cost-effective way to aid in the detection of bladder cancer in patients at risk. The use of the NMP22 protein has been FDA-approved four times for various formats and claims, most recently in April 2003 for ...
Company:Matritech, Inc.
Description:... for the qualititive ("yes or "no) detection of bladder tumor associated antigen. It is indicated for use as an aid in the management of bladder cancer in conjunction with cystoscopy or when prescribed for in home use. BTA stat Test was cleared by the FDA for prescription home use in February 1999. ...
Company:Mentor Corporation
Description:... of bladder tumor antigen in urine of persons diagnosed with bladder cancer. This test is indicated for use as an aid in the management of bladder cancer patients in conjunction with ....
Company:Polymedco Inc.
Company:Siemens Medical Solutions Diagnostics
Description:... Ovarian cancer ...
Company:Beckman Coulter, Inc.
Description:... Enzyme immunoassay for the quantitative determination of ovarian cancer antigen CA125 in human ...
Company:Bio-Quant, Inc.
Company:Diagnostic Automation, Inc.
Description:... with prostate cancer. Of the different PSA blood tests available, the Hybritech PSA test, was the first approved for the detection of prostate cancer when used in combination with digital rectal examination (DRE) in men aged 50 years or older. Depending on the results of your DRE and total PSA ...
Company:Beckman Coulter, Inc.
Description:... (PSA) in human serum. This in vitro device is strictly intended to help in the screening, management and prognosis of patients with prostate cancer at various stage of the ....
Company:YES Biotech Laboratories Ltd.
Company:Diagnostic Systems Laboratories, Inc.
Access Hybritech® free PSA Test
Description:... PSA will help improve the accuracy of prostate cancer detection. PSA exists in multiple forms in the ... PSA could further help in distinguishing prostate cancer from benign prostate disease. The Hybritech® ... free PSA improves the accuracy of prostate cancer detection while eliminating a projected 20 ...Company:Beckman Coulter, Inc.
Description:... with the volume and clinical stage of prostate cancer [1,4]. Selective determination of the various ... PSA to PSA-ACT is lower in untreated prostate cancer patients than in normal individuals or in ... discrimination between BPH and untreated prostate cancer in patients [1,3,5,6]. It has been found ...
Company:Diagnostic Systems Laboratories, Inc.
MammaPrint Breast Cancer Diagnostic Test
Description:... expression profiling test that predicts the risk of metastasis in breast cancer patients. It is based on groundbreaking research performed at the Netherlands cancer Institute and the Antoni Van Leeuwenhoek Hospital in Amsterdam, The ...Company:Agendia Corporate
Physicians' Cancer Chemotherapy Drug Manual 2005
Description:... for 2005, this practical handbook is an up-to-date guide to all aspects of cancer chemotherapy. The book provides a comprehensive, easy to use catalog of over 100 drugs both on and off label commonly used in cancer treatment. This new edition includes new agents (recently or about to be ...Company:Skyscape, Inc.
TargetScan Targeted Prostate Biopsy System
Description:... TargetScan(R) is the latest innovation in prostate mapping, biopsy and cancer treatment guidance. Combining 3-D image acquisition with a stationary ... and execute targeted prostate biopsies -- potentially improving patients' cancer treatment outcomes with less-invasive ....Company:Envisioneering Medical Technology
Total Prostate Specific Antigen
Description:... human serum or plasma. It is used as an aid in the detection of prostate cancer and in the management of prostate cancer ....Company:Dade Behring, Inc.
NMP22® BladderChek® Kit (1-test kit)
Description:... is a quantitative microplate enzyme immunoassay that can identify bladder cancer patients who are at risk for rapid recurrence or occult disease. The test ... protein is present at low levels. The majority of patients with bladder cancer release large quantities of NMP22 into their ....Company:Matritech, Inc.
NMP22® BladderChek® Kit (24-test kit)
Description:... is a quantitative microplate enzyme immunoassay that can identify bladder cancer patients who are at risk for rapid recurrence or occult disease. The test ... protein is present at low levels. The majority of patients with bladder cancer release large quantities of NMP22 into their ....Company:Matritech, Inc.
Description:... in most tumors. The liver is a principal site for metastasis of primary cancer originating in other parts of the body, particularly colon cancer, which is a common cancer in the United States. The ability to identify metastatic tumors in the ...
Company:Advanced Magnetics, Inc.
NMP22 Bladder Cancer ELISA Test Kit
Description:... Inverness Medical Professional Diagnostics now offers the first and only NMP22 ELISA test for the screening and monitoring of bladder cancer patients. The NMP22 Test Kit is a quantitative microplate enzyme immunoassay that detects elevated levels of NMP22 protein in the urine of patients ...Company:Inverness Medical Innovations
Pocket Guide to Chemotherapy Protocols, 2nd Edition
Description:... A handy, quick reference for physicians, nurses, and other health care providers treating cancer ....Company:Skyscape, Inc.
Description:... traditional guaiac-based FOBTs. Because of its superior specificity for lower GI bleeding, Hemoccult ICT is an ideal screening tool for colorectal cancer (CRC), and this specificity also reduces the number of false positive test results. Safe and non-invasive, Hemoccult ICT is very patient friendly, as ...
Company:Beckman Coulter, Inc.
Hemoccult ICT Fecal Occult Blood Test
Description:... traditional guaiac-based FOBTs. Because of its superior specificity for lower GI bleeding, Hemoccult ICT is an ideal screening tool for colorectal cancer (CRC), and this specificity also reduces the number of false positive test results. Safe and non-invasive, Hemoccult ICT is very patient friendly, as ...Company:Beckman Coulter, Inc
BD Cell-Tak™ Cell and Tissue Adhesive
Description:... and establishing primary cells in culture. BD Cell-Tak Cell and Tissue Adhesive has been used successfully with sperm cells, T47D human breast cancer cells, and ....Company:BD Diagnostic Systems
Description:... diagnostic test for the clinical evaluation of GH-related disorders. Additionally, there is a growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. Vit Horm 47:1-114, 1993. Juul A. et al. J Clin ...
Company:Diagnostic Systems Laboratories, Inc.
IGF-I IRMA Test (With Extraction)
Description:... diagnostic test for the clinical evaluation of GH-related disorders. Additionally, there is a growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. Vit Horm 47:1-114, 1993. Juul A. et al. J Clin ...Company:Diagnostic Systems Laboratories, Inc.
IGF-I ELISA Test (With Extraction)
Description:... diagnostic test for the clinical evaluation of GH-related disorders. Additionally, there is a growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. Vit Horm 47:1-114, 1993. Juul A. et al. J Clin ...Company:Diagnostic Systems Laboratories, Inc.
IGF-I IRMA Test (Non-Extraction)
Description:... diagnostic test for the clinical evaluation of GH-related disorders. Additionally, there is a growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. Vit Horm 47:1-114, 1993. Juul A. et al. J Clin ...Company:Diagnostic Systems Laboratories, Inc.
IGF-I ELISA Test (Non-Extraction)
Description:... diagnostic test for the clinical evaluation of GH-related disorders. Additionally, there is a growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. Vit Horm 47:1-114, 1993. Juul A. et al. J Clin ...Company:Diagnostic Systems Laboratories, Inc.
Description:... diagnostic test for the clinical evaluation of GH-related disorders. Additionally, there is a growing research interest in the role of IGF-I in cancer risk assessment [8.9]. Baxter RC, et al. J Biol Chem 264:11843-11848, 1989. Rechler M. Vit Horm 47:1-114, 1993. Juul A. et al. J Clin ...
Company:Diagnostic Systems Laboratories, Inc.
Description:... Oncotype DX™ is a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses ...
Company:Genomic Health, Inc.
Description:... in situ hybridization (FISH) assay designed to quantitatively determine HER2 gene amplification in formalin-fixed, paraffin-embedded breast cancer tissue specimens. Gene amplification is determined from the ratio between the number of signals from the hybridization of the HER2 gene probe (red ...
Company:DakoCytomation California Inc.
Description:... The Her-2/neu protein is a 185 kD trans-membrane glycoprotein associated with tyrosine kinase activity. Approximately 20-30% cases of breast cancer show an amplification and/or over-expression of Her-2/neu in tumor cells. Since the introduction of Herceptin® as a targeted therapy for breast ...
Company:BioGenex Laboratories
Self-Retaining Bicanaliculus Intubation Set
Description:... Primary indications for the SRS include horizontal lacrimal duct stricture and punctal stenosis. Special consideration should be given to cancer patients on constricting drug therapies such as ....Company:FCI Ophthalmics Inc.
Insulin-like Growth Factor-I (IGF-I) ELISA
Description:... of IGF-I, the whole process being completed within 4 hours. The OCTEIATM IGF-I ELISA is being used increasingly in studies associated with growth, cancer and bone ....Company:IDS Ltd
Description:... tool in determining functionality of a patient's immune system, particularly important when deciding courses of treatment for patients receiving cancer chemotherapy, immunosuppressive treatment, recurring infections and autoimmune dieseases. Kit 030 designed especially for patients with autoimmune ...
Company:AntibodyShop A/S
Description:... tool in determining functionality of a patient's immune system, particularly important when deciding courses of treatment for patients receiving cancer chemotherapy, immunosuppressive treatment, recurring infections and autoimmune ....
Company:AntibodyShop A/S
Lyphochek Tumor Marker Control
Description:... Lyphochek Tumor Marker Control is a comprehensive, bilevel product designed to assess the performance of various cancer antigen tests, including esoteric tumor ....Company:Bio-Rad Laboratories
Vysis UroVysion Bladder Cancer Kit
Description:... The UroVysion Bladder cancer Kit (UroVysion Kit) is designed to detect aneuploidy for chromosomes 3, 7, 17, and loss of the 9p21 locus via fluorescence in situ hybridization ...Company:Abbott Diagnostics
Description:... A Powerful New Quantitative Immunoassay for Monitoring Bladder cancer Patients. Useful in Monitoring Patients for Disease Progression and ....
Company:Polymedco Inc.
Description:... office with results delivered during the patient visit, allowing a rapid, accurate and cost-effective way to aid in the detection of bladder cancer in patients at risk. The use of the NMP22 protein has been FDA-approved four times for various formats and claims, most recently in April 2003 for ...
Company:Matritech, Inc.
Description:... for the qualititive ("yes or "no) detection of bladder tumor associated antigen. It is indicated for use as an aid in the management of bladder cancer in conjunction with cystoscopy or when prescribed for in home use. BTA stat Test was cleared by the FDA for prescription home use in February 1999. ...
Company:Mentor Corporation
Description:... of bladder tumor antigen in urine of persons diagnosed with bladder cancer. This test is indicated for use as an aid in the management of bladder cancer patients in conjunction with ....
Company:Polymedco Inc.
Coat-A-Count AFP IRMA (Alpha Fetoprotein)
Description:... for in vitro use in either of two contexts: (a) serial measurements to aid in the management of patients with nonseminomatous testicular cancer and other conditions associated with abnormal AFP production; or (b) measurements in maternal serum during gestational weeks 15 through 21 ...Company:Siemens Medical Solutions Diagnostics
Description:... Ovarian cancer ...
Company:Beckman Coulter, Inc.
Description:... Enzyme immunoassay for the quantitative determination of ovarian cancer antigen CA125 in human ...
Company:Bio-Quant, Inc.
CA-125 Enzyme Immunoassay Test Kit
Description:... Enzyme Immunoassay for the Quantitative Measurement of Ovarian cancer Antigen CA-125 in Human ...Company:Diagnostic Automation, Inc.
Description:... with prostate cancer. Of the different PSA blood tests available, the Hybritech PSA test, was the first approved for the detection of prostate cancer when used in combination with digital rectal examination (DRE) in men aged 50 years or older. Depending on the results of your DRE and total PSA ...
Company:Beckman Coulter, Inc.
Description:... (PSA) in human serum. This in vitro device is strictly intended to help in the screening, management and prognosis of patients with prostate cancer at various stage of the ....
Company:YES Biotech Laboratories Ltd.
Other ContentsglomerulonephritisglaucomaglaucomaglaucomaglossitisglazesgliomasgliomasgliomasgonadOther TagsJuvenileTasteTasteWardsWardsWardsWardsMultivitamin
(Date:11/9/2009)...rit responsible for the rapid, mysterious death of...n found by collaborating scientists at Rutgers Uni...on (WHOI). This same chemical may hold unexpected...ed a previously unknown lipid, or fatty compound, ...iliania huxleyi , a phytoplankton that plays a maj...
(Date:11/8/2009)...ION DESIGNED FOR ADULTS WITH INTELLECTUAL DISABILI...ndiana University study involving adults with inte...sed their personal health knowledge after taking a...h ID, an internationally accepted term for mental ..., physical inactivity and preventable chronic dise...
(Date:11/6/2009)...ember 06, 2009) The Monell Center and the Chinese...jing International Meeting on Taste and Smell Rese...e CAS, the meeting will be the first international..., Alan Leshner, Chief Executive Officer, American...ecutive Publisher of Science magazine, will open t...
Breaking Biology News(10 mins):Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Mothers Cancer Can Pass to Fetus 59306 1Mothers Cancer Can Pass to Fetus 59306 2Novel Facebook Application Aims to Prevent Cervical Cancer 59302 1Novel Facebook Application Aims to Prevent Cervical Cancer 59302 2Laser Spine Institute Helping Patients with Debilitating Back Pain at New Medical Consultation Facilities in Beverly Hills and Fort Lauderdale 59298 1Laser Spine Institute Helping Patients with Debilitating Back Pain at New Medical Consultation Facilities in Beverly Hills and Fort Lauderdale 59298 2(Date:11/9/2009)... Fast food chains are ofte...sity. A recent poll by Fitness.com.au however find...ulder the responsibility. , ... food chains, and video games were behind Australi...Dad are more than just innocent bystanders. A rece...
(Date:11/9/2009)..., The National Comprehensive Cancer Network (NC...ent that details a draft paradigm for near-term co... upon existing data. The document introduces the N...sensus-based process that compares the risk-versus...d in the NCCN Clinical Practice Guidelines in Onco...
(Date:11/9/2009)..., CHICAGO, Nov. 9 Highlighting ...titutions with advanced entertainment and digital ...casing its latest Long-Term Care and Hospital Grad...and Services for the Aging 2009 annual meeting and...s booth, the new line of "HealthView(TM)" Long-Ter...
(Date:11/9/2009)...tudy didn,t answer question of why this is so, how...s) -- After a lumpectomy, women with very dense br...he affected breast, a new study shows. , Breast... risk of developing breast cancer, and experts hav...sociated with an increased risk of cancer recurren...
(Date:11/9/2009)..., CAMBRIDGE, Mass., Nov. 9 Ab...d capabilities in delivering emergency management ...y awarded contracts to support the work of the Fed...f Regional Operations, the National Commission on ...itan Area Transit Authority (WMATA). The value of...
Breaking Medicine News(10 mins):Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2[1] Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids[0] NCCN Posts Comparative Effectiveness White Paper for Public Comment[0] LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs[0] Dense Breasts Raise Risk of Cancer Recurrence[0] Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority
LaxativesFluoridatedMifepristoneCostliestDustedJuvenileAcompliaJambaTasteUnholyWardsChlorpyrifosMultivitaminHeavenly
Other Tagsplain 2plain 3hormonal 2hormonal 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |